Results 1 to 10 of about 100,926 (300)
Neuropsychiatric Disease and Treatment, 2014 Taro Kishi, Shinji Matsunaga, Yuki Matsuda, Nakao Iwata Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan Background: We conducted a meta-analysis of the iminodibenzyl antipsychotics carpipramine, clocapramine, and ...
Kishi T, Matsunaga S, Matsuda Y, Iwata N
doaj +1 more source
The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism [PDF]
Journal of Medicine and Life Science, 2021 Atypical antipsychotics are more effective than typical antipsychotics and have fewer side effects such as tardive dyskinesia and extrapyramidal symptoms; therefore, prescriptions of atypical antipsychotics are increasing.
Sang Ah Lee, Suk Ju Cho, Jae Cheol Moon
doaj +1 more source
Torsadogenic risk of antipsychotics : combining adverse event reports with drug utilization data across Europe [PDF]
, 2013 Antipsychotics (APs) have been associated with risk of torsade de Pointes (TdP). This has important public health implications. Therefore, (a) we exploited the public FDA Adverse Event Reporting System (FAERS) to characterize their torsadogenic profile; (
Kalaba, Marija +10 more
core +3 more sources
Schizophrenia:Practical prescribing of antipsychotics [PDF]
, 2018 Schizophrenia is commonly treated with antipsychotics. This article presents a major overview of prescribing antipsychotic for the non-medical prescriber.
Hemingway, Stephen, Haygarth, Lynn
core +10 more sources
Intellectual disability and antipsychotics
European Psychiatry, 2021 Introduction Intellectual disability is a condition of cognitive impairment and deficit in adaptive skills. Mental illness is frequent in people with intellectual disability.
I. Cuevas Iñiguez, M.D.C. Molina Lietor
doaj +1 more source
Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia. [PDF]
PLoS ONE, 2012 BACKGROUND: Several reports on patients with chronic schizophrenia suggest that atypical versus typical antipsychotics are expected to lead to better quality of life (QOL) and cognitive function.
Koichiro Fujimaki +2 more
doaj +1 more source
Pharmaceuticals, 2020 The pharmacological treatment of cognitive impairments associated with schizophrenia is still a major unmet clinical need. Indeed, treatments with available antipsychotics generate highly variable cognitive responses among patients with schizophrenia ...
Sebastiano Alfio Torrisi +9 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Objective: This study aimed to investigate the characteristics and spectrum of cardiotoxicity induced by various antipsychotics based on the United States Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database.Methods: Data of
Luyao He +5 more
doaj +1 more source
BMC Pulmonary Medicine, 2022 Background Severe asthma exacerbation reduces patients’ quality of life, results in visits to the emergency department (ED) and hospitalization, and incurs additional medical costs.
Chin-Wei Kuo +4 more
doaj +1 more source
Pharmacogenetics of Antipsychotics [PDF]
The Canadian Journal of Psychiatry, 2014 Objective: During the past decades, increasing efforts have been invested in studies to unravel the influence of genetic factors on antipsychotic (AP) dosage, treatment response, and occurrence of adverse effects.
Eva J, Brandl +2 more
openaire +2 more sources